PL EN


Preferences help
enabled [disable] Abstract
Number of results
2010 | 58 | 1 | 45-56
Article title

The role of heparanase in diseases of the glomeruli

Title variants
Languages of publication
EN
Abstracts
EN
The glomerular basement membrane (GBM) is a kind of net that remains in a state of dynamic equilibrium. Heparan sulfate proteoglycans (HSPGs) are among its most important components. There are much data indicating the significance of these proteoglycans in protecting proteins such as albumins from penetrating to the urine, although some new data indicate that loss of proteoglycans does not always lead to proteinuria. Heparanase is an enzyme which cleaves 1,4 d-glucuronic bonds in sugar groups of HSPGs. Thus it is supposed that heparanase may have an important role in the pathogenesis of proteinuria. Increased heparanase expression and activity in the course of many glomerular diseases was observed. The most widely documented is the significance of heparanase in the pathogenesis of diabetic nephropathy. Moreover, heparanase acts as a signaling molecule and may influence the concentrations of active growth factors in the GBM. It is being investigated whether heparanase inhibition may cause decreased proteinuria. The heparanase inhibitor PI-88 (phosphomannopentaose sulfate) was effective as an antiproteinuric drug in an experimental model of membranous nephropathy. Nevertheless, this drug is burdened by some toxicity, so further investigations should be considered.
Publisher

Year
Volume
58
Issue
1
Pages
45-56
Physical description
Contributors
author
author
author
References
Document Type
REVIEW
Publication order reference
Marian?Klinger, Department of Nephrology and Transplantation Medicine, Wroclaw Medical University, Traugutta 57/59, Wroclaw, Poland
Identifiers
YADDA identifier
bwmeta1.element.element-from-psjc-1d6e8aa5-720d-3499-8ca7-ab38d2b29b0c
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.